![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1368677
»ý¸®½Ä¿°¼ö ½ÃÀå ±Ô¸ð : ¾àÁ¦ À¯Çü, Æ÷Àå À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ¼¼°è ¿¹Ãø(2023-2032³â)Physiological Saline Market Size - Drug Type (Normal Saline, Hypotonic), Packaging Type (Flexible Bag, Plastic Bottle), Application (Chronic Disease, Acute Health Conditions), End-user, Global Forecast 2023 - 2032 |
¼¼°èÀÇ »ý¸®½Ä¿°¼ö ½ÃÀåÀº 2023-2032³â 6.2%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î »ý°¢µË´Ï´Ù.
»ý¸®½Ä¿°¼ö´Â Á¤¸ÆÁÖ»ç, »óó ¼¼Ã´ ¹× Áø´Ü ÀýÂ÷¿¡ ÇʼöÀûÀ̸ç, ÇコÄɾîÀÇ Áß¿äÇÑ ÄÄÆ÷³ÍÆ®·Î ³²¾Æ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¸¼ºÁúȯ°ú ¼ö¼ú Áõ°¡µµ ½Ä¿°¼ö ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¿¹¸¦ µé¾î WHOÀÇ 2023³â 9¿ù Åë°è¿¡ µû¸£¸é ºñ°¨¿°¼º Áúȯ(NCDs)Àº ¸Å³â 4,100¸¸ ¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°¡¸ç ¼¼°è ÃÑ »ç¸Á·üÀÇ 74%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¶ÇÇÑ ¸Å³â 1,700¸¸ ¸íÀÌ 70¼¼ ÀÌÀü¿¡ NCDs·Î ÀÎÇØ »ç¸ÁÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áúº´ÀÌ Á¶±â »ç¸Á·ü¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ È£Èí±â Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ´õ¿í ³ô¾ÆÁ³½À´Ï´Ù. ȯÀÚµéÀÇ °Ç°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÚ¿¬½º·´°í ¾ÈÀüÇÑ Á¦Ç°À» ¼±È£ÇÏ´Â °æÇâÀÌ ³ô¾ÆÁ® ½Ä¿°¼ö¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½Ä¿°¼ö ½ÃÀå Àü¸ÁÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¸¸¼ºÁúȯ ºÐ¾ß´Â 2023-2032³â Å©°Ô ¹ßÀüÇÒ °ÍÀÔ´Ï´Ù. ÀÌ ¹«±ÕÀÇ ±ÕÇü ÀâÈù ¼Ò±Ý ¿ë¾×Àº ´ç´¢º´, ½ÅÀå Áúȯ, ½ÉÇ÷°ü Áúȯ°ú °°Àº ´Ù¾çÇÑ ¸¸¼º °Ç° »óÅÂÀÇ Ä¡·á ¹× °ü¸®¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¼¼°è¿¡¼ ¸¸¼ºÁúȯÀÇ ºÎ´ãÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó »ý¸®½Ä¿°¼ö ½ÃÀå¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó °ß°íÇÏ°Ô À¯ÁöµÇ°í ÀÖÀ¸¸ç, ÇコÄɾ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ºÎ¹®Àº 2023-2032³â µÎµå·¯Áø CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿Ü·¡ ¼ö¼ú¿¡ ÁßÁ¡À» µÐ ÀÌµé ½Ã¼³Àº ¼ö¼ú Àü ¼öºÐ °ø±Þ, »óó °ü°³, ¼ö¼ú ÈÄ °ü¸® µî ´Ù¾çÇÑ ÀÇ·á¿ë ½Ä¿°¼ö¸¦ »ç¿ëÇϰí ÀÖÀ¸¸ç, ASCÀÇ ¼ºÀå Ãß¼¼¿¡ µû¶ó ½Ä¿°¼ö ½ÃÀå Á¡À¯À²Àº °ß°íÇÏ°Ô À¯ÁöµÇ°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ È¯°æ¿¡¼ ¾ÈÀüÇϰí È¿°úÀûÀÎ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
À¯·´ÀÇ »ý¸®½Ä¿°¼ö ½ÃÀåÀº 2023-2032³â µÎµå·¯Áø CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ´ë·úÀÇ °í·ÉÈ´Â ¸¸¼ºÁúȯ Áõ°¡¿Í ÇÔ²² ÀÇ·á ȯ°æ¿¡¼ ½Ä¿°¼ö ¼Ö·ç¼ÇÀÇ Çʿ伺À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î À¯·Î½ºÅ¸Æ®(Eurostat)ÀÇ º¸°í¼¿¡ µû¸£¸é ¿¬·Éº° ¿¹Ãø¿¡ µû¸£¸é 2050³â±îÁö EU-27¿¡¼ °ÅÀÇ 50¸¸ ¸íÀÇ ¹é¼ö Àα¸°¡ ź»ýÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´ÀÇ ³ôÀº ÀÇ·á ¼öÁØÀº ¾ö°ÝÇÑ ¾ÈÀü ±ÔÁ¦¿Í ÇÔ²² ½Ä¿°¼öÀÇ Á߿伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÇàÀ§°¡ °è¼Ó ÁøÈÇÏ´Â °¡¿îµ¥, ÀÌ Çʼö ÀÇ·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä´Â À¯·´ ÀÇ·á ȯ°æ¿¡¼ °è¼Ó °ß°íÇÏ°Ô À¯ÁöµÇ°í ÀÖ½À´Ï´Ù.
Global Physiological Saline Market will witness 6.2% CAGR between 2023 and 2032. it remains a crucial component in healthcare, essential for intravenous fluids, wound cleansing, and diagnostic procedures. In addition, the rising prevalence of chronic diseases and surgical interventions contributes to increased demand for saline solutions.
For instance, according to September 2023 stats from WHO, noncommunicable diseases (NCDs) claim the lives of 41 million individuals annually, accounting for 74% of the total global mortality. Furthermore, each year, 17 million people succumb to NCDs before reaching the age of 70, underscoring the significant impact of these diseases on premature mortality. Furthermore, the COVID-19 pandemic highlighted its use for respiratory care. As patients become more health-conscious, there's a growing preference for natural and safe products, boosting the demand for physiological saline solutions. These factors collectively propel the physiological saline market outlook.
The overall Physiological Saline Market is classified based on application, end-user, and region.
The chronic diseases segment will undergo significant development from 2023 to 2032. This sterile and balanced salt solution plays a pivotal role in the treatment and management of various chronic health conditions, such as diabetes, kidney disease, and cardiovascular issues. As the global burden of chronic diseases continues to rise, the physiological saline market demand remains robust, making it an indispensable component in healthcare.
The ambulatory surgical centers segment will register a commendable CAGR from 2023 to 2032. These facilities, focused on outpatient procedures, rely on saline solutions for various medical applications, including pre-operative hydration, wound irrigation, and post-operative care. As the trend toward ASCs continues to grow, the physiological saline market share remains strong, supporting its crucial role in providing safe and effective healthcare in these settings.
Europe physiological saline market will showcase an appreciable CAGR from 2023 to 2032. The continent's aging population, in line with a rising prevalence of chronic diseases, fuels the need for saline solutions in healthcare settings. For instance, according to a report from Eurostat, an age-based projection indicates that the EU-27 is expected to have nearly 500,000 centenarians by the year 2050. The high healthcare standards in Europe, in tandem with stringent safety regulations, emphasize the significance of physiological saline. As medical practices continue to evolve, the demand for this essential medical product remains robust in the European healthcare landscape.